Pfizer enters 2026 facing earnings pressure from COVID revenue collapse and acquisition-related dilution. Click here to read ...
M+C Saatchi North America is turning to a longtime pharma pro to serve as its inaugural medical advisor. | M+C Saatchi North ...
In 2026, Oropouche outbreaks will likely continue to affect travelers in the Americas. The biting midge that carries ...
Slingshot News on MSNOpinion
'You know who I'm talking about': Trump fails to defeat dementia as he gives up on trying to remember Hakeem Jeffries in Oval Office remarks
Donald Trump announced a drug deal with Pfizer in the Oval Office several months ago in September. During his remarks to the ...
24/7 Wall St. on MSN
Fed Governor Wants Huge Rate Cuts This Year: 5 High-Yield Dividend Stocks to Buy Today
These five high-yield dividend stocks with solid upside potential and Buy ratings make sense for growth and income investors ...
With a lioness-themed rebrand tied to its latest buy, Athira Pharma is roaring into the new year under its second new moniker. | The LeonaBio rebrand comes from the name Leona, which means lioness ...
The federal government is no longer broadly recommending several vaccines as part of the Trump administration and Health ...
Imports decreased 3.2%, reflecting declines in inbound shipments of medication and nonmonetary gold. Imports of pharmaceutical preparations dropped to the lowest since July 2022. The value of all US ...
Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...
A distinguished cohort of four West Virginia University graduates will be inducted into the Academy of Distinguished Alumni ...
A systematic review and meta-analysis published in the BMJ looks at weight regain after stopping obesity drugs. Prof Jason Halford, Professor of Biological Psychology and Health Behaviours, University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback